COVID-19 vaccination in adults with inflammatory bowel disease
Patients with inflammatory bowel disease (IBD) are not at increased risk of SARS-CoV-2 infection compared to the general population, and most are not at increased risk for severe disease. COVID-19 is nonetheless common, and vaccination is critical. Four safe and efficacious vaccines are now availabl...
Main Authors: | Megan Lutz, Sarah Lazarus, Freddy Caldera |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2023-05-01
|
Series: | Therapeutic Advances in Gastroenterology |
Online Access: | https://doi.org/10.1177/17562848231173130 |
Similar Items
-
COVID-19 Vaccination in Inflammatory Bowel Disease (IBD)
by: Aleksandra Kubas, et al.
Published: (2022-05-01) -
Response to COVID-19 Vaccination in Patients with Inflammatory Bowel Disease on Biological Treatment
by: Giorgia Bodini, et al.
Published: (2022-05-01) -
Acceptance of COVID-19 Vaccines among Patients with Inflammatory Bowel Disease in Japan
by: Yu Nishida, et al.
Published: (2021-12-01) -
Misconceptions Drive COVID-19 Vaccine Hesistancy in Individuals with Inflammatory Bowel Disease
by: Eva Zhang, et al.
Published: (2022-01-01) -
Clinical and Laboratory Outcomes of Inflammatory Bowel Disease Patients after COVID-19 Vaccination
by: Ahmad Raeisi, et al.
Published: (2023-10-01)